OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
NWND51

New Nordic Healthbrands AB

Food ProcessingVerified

New Nordic Healthbrands AB maintains a relatively balanced capital structure, with a debt-to-equity ratio of 0.35, indicating a moderate reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 1.6, suggesting it can cover its short-term obligations but with limited buffer. However, the company's net cash position is negative after subtracting total debt, which raises concerns about its short-term liquidity. In terms of profitability, the company's return on equity (ROE) is 7.92%, and its return on assets (ROA) is 3.33%. These figures are below the typical thresholds for strong performance in the food processing industry, indicating that the company is not generating returns at a level that would be considered robust by industry standards. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no significant geographic diversification reported. This lack of diversification could expose the company to higher risk if demand in its primary market fluctuates. The company's growth trajectory appears to be modest, with limited data available on year-over-year revenue changes. The operating cash flow of 8.39 million SEK and free cash flow of 7.19 million SEK suggest the company is generating positive cash from operations, but the capital expenditure of -3.47 million SEK indicates some investment in maintaining or expanding its operations. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's net cash position being negative after subtracting total debt is a key flag, indicating potential liquidity constraints. The dilution risk is low, with no significant dilution potential reported in the basic shares outstanding. Recent events and filings do not indicate any major changes in the company's operations or financial strategy. The company's financial statements and disclosures do not mention any significant new projects, partnerships, or regulatory changes that would impact its near-term performance.

30-day price · NWND-1.05 (-6.1%)
Low$15.00High$19.70Close$16.10As of17 May, 00:00 UTC
Profile
CompanyNew Nordic Healthbrands AB
TickerNWND.ST
SectorConsumer Non-Cyclicals
BusinessFood & Beverages
Industry groupFood & Beverages
IndustryFood Processing
AI analysis

Business. (unavailable from LLM output)

Classification. (unavailable from LLM output)

New Nordic Healthbrands AB maintains a relatively balanced capital structure, with a debt-to-equity ratio of 0.35, indicating a moderate reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 1.6, suggesting it can cover its short-term obligations but with limited buffer. However, the company's net cash position is negative after subtracting total debt, which raises concerns about its short-term liquidity. In terms of profitability, the company's return on equity (ROE) is 7.92%, and its return on assets (ROA) is 3.33%. These figures are below the typical thresholds for strong performance in the food processing industry, indicating that the company is not generating returns at a level that would be considered robust by industry standards. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no significant geographic diversification reported. This lack of diversification could expose the company to higher risk if demand in its primary market fluctuates. The company's growth trajectory appears to be modest, with limited data available on year-over-year revenue changes. The operating cash flow of 8.39 million SEK and free cash flow of 7.19 million SEK suggest the company is generating positive cash from operations, but the capital expenditure of -3.47 million SEK indicates some investment in maintaining or expanding its operations. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's net cash position being negative after subtracting total debt is a key flag, indicating potential liquidity constraints. The dilution risk is low, with no significant dilution potential reported in the basic shares outstanding. Recent events and filings do not indicate any major changes in the company's operations or financial strategy. The company's financial statements and disclosures do not mention any significant new projects, partnerships, or regulatory changes that would impact its near-term performance.
Key takeaways
  • New Nordic Healthbrands AB has a moderate debt-to-equity ratio of 0.35, indicating a balanced capital structure.
  • The company's ROE of 7.92% and ROA of 3.33% are below industry benchmarks, suggesting suboptimal returns.
  • The company's liquidity position is medium, with a current ratio of 1.6 and a negative net cash position after debt.
  • The company's revenue is concentrated in a single segment, increasing exposure to market fluctuations.
  • The company's growth trajectory is modest, with positive operating and free cash flows but limited capital expenditure.
  • The company faces medium liquidity risk and low dilution risk, with no significant dilution potential reported.
  • --
  • **RATIONALES**:
Financial snapshot
PeriodHA-latest
CurrencySEK
Revenue$576.4M
Gross profit$370.4M
Operating income$15.1M
Net income$8.2M
R&D
SG&A
D&A
SBC
Operating cash flow$8.4M
CapEx-$3.5M
Free cash flow$7.2M
Total assets$246.2M
Total liabilities$142.7M
Total equity$103.5M
Cash & equivalents$16.5M
Long-term debt$35.8M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$103.5M
Net cash-$19.3M
Current ratio1.6
Debt/Equity0.3
ROA3.3%
ROE7.9%
Cash conversion1.0%
CapEx/Revenue-0.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Food Processing · cohort 1040 companies
MetricNWNDActivity
Op margin2.6%5.6% medp25 2.1% · p75 11.2%below median
Net margin1.4%3.9% medp25 0.5% · p75 8.5%below median
Gross margin64.3%23.3% medp25 14.8% · p75 32.6%top quartile
R&D / revenue0.8% medp25 0.5% · p75 2.3%
CapEx / revenue-0.6%-4.1% medp25 -8.9% · p75 -1.9%top quartile
Debt / equity35.0%37.6% medp25 7.2% · p75 84.5%below median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-16 16:40 UTC#8959f657
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 19:40 UTCJob: 59febb5d